                                 CODE OF VIRGINIA

DUTIES OF THE COMMITTEE (§ 32.1-331.14)

A. The Committee shall make recommendations to the Board regarding drugs or
categories of drugs to be subject to prior authorization and prior authorization
requirements for prescription drug coverage under the state plan, as well as any
subsequent amendments to or revisions of such prior authorization requirements
from time to time. The Board may accept or reject such recommendations in whole
or in part, and may amend or add to such recommendations, except that the Board
may not add to the recommendation of drugs and categories of drugs to be subject
to prior authorization.

B. In formulating its recommendations to the Board, the Committee shall not be
deemed to be formulating regulations for the purposes of the Administrative
Process Act (&#xA7; 2.2-4000 et seq.). The Committee shall, however, conduct
public hearings prior to making such recommendations to the Board. The Committee
shall give thirty days&#8217; written notice by mail of the time and place of
its hearings and meetings to any manufacturer whose product is being reviewed by
the Committee and to those manufacturers who request the Committee in writing
that they be informed of such hearings and meetings. Such persons shall be
afforded a reasonable opportunity to be heard and present information. In
addition, the Committee shall give thirty days&#8217; notice of such public
hearings to the public by publishing its intention to conduct hearings and
meetings in the Calendar of Events of the Virginia Register of Regulations and a
newspaper of general circulation located in Richmond.

C. In acting on the recommendations of the Committee, the Board shall be
required to conduct further proceedings under the Administrative Process Act.

HISTORY: 1993, c. 537.